Influence of ghrelin on food intake and energy homeostasis

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 10, Issue 5, 2007, Pages 615-619

  De Vriese, Carine ^a   Delporte, Christine ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Appetite; Energy homeostasis; Food intake; Ghrelin; Obesity

Indexed keywords

GHRELIN; GHRELIN VACCINE; HORMONE RECEPTOR BLOCKING AGENT; LEPTIN; UNCLASSIFIED DRUG; VACCINE;

APPETITE; BODY WEIGHT; CACHEXIA; ENERGY BALANCE; FOOD INTAKE; HORMONE ACTION; HUMAN; MEAL; OBESITY; POSTPRANDIAL STATE; PROTEIN INTERACTION; REVIEW; STOMACH;

ANOREXIA; APPETITE; BODY WEIGHT; ENERGY INTAKE; ENERGY METABOLISM; GHRELIN; HUMANS; LEPTIN; OBESITY;

EID: 34547878048     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32829fb37c     Document Type: Review

References (73)

1. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409:194-198.
2. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86:5992-5995.
3. Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50:1714-1719.
4. Natalucci G, Riedl S, Gleiss A, et al. Spontaneous 24-h ghrelin secretion pattern in fasting subjects: maintenance of a meal-related pattern. Eur J Endocrinol 2005; 152:845-850.
5. Huda MS, Wilding JP, Pinkney JH. Gut peptides and the regulation of appetite. Obes Rev 2006; 7:163-182.
6. Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37:649-661.
7. Kamegai J, Tamura H, Shimizu T, et al. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001; 50:2438-2443.
8. Chen HY, Trumbauer ME, Chen AS, et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004; 145:2607-2612.
9. Luquet S, Phillips CT, Palmiter RD. NPY/AgRP neurons are not essential for feeding responses to glucoprivation. Peptides 2007; 28:214-225.
10. Kohno D, Nakata M, Maekawa F, et al. Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway. Endocrinology 2007; 148:2251-2263. This paper identifies the pathway through which ghrelin and leptin counteract in NPY neurons.
11. Coiro V, Saccani-Jotti G, Rubino P, et al. Effects of ghrelin on circulating neuropeptide Y levels in humans. Neuro Endocrinol Lett 2006; 27:755-757.
12. Scott V, McDade DM, Luckman SM. Rapid changes in the sensitivity of arcuate nucleus neurons to central ghrelin in relation to feeding status. Physiol Behav 2007; 90:180-185.
13. Yamanaka A, Beuckmann CT, Willie JT, et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003; 38:701-713.
14. Toshinai K, Date Y, Murakami N, et al. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 2003; 144:1506-1512.
15. Date Y, Shimbara T, Koda S, et al. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell Metab 2006; 4:323-331.
16. Riediger T, Traebert M, Schmid HA, et al. Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neurosci Lett 2003; 341:151-155.
17. de Lartigue G, Dimaline R, Varro A, Dockray GJ. Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin. J Neurosci 2007; 27:2876-2882. Ghrelin inhibits the anorexigenic effect of cholecystokinin at least in part through control of the nuclear localization of phospho-CREB (cAMP-response-element binding protein), identifying a new pathway involved in control of food intake.
18. Solomon A, De Fanti BA, Martinez JA. Peripheral ghrelin participates in glucostatic feeding mechanisms and in the anorexigenic signalling mediated by CART and CRF neurons. Nutr Neurosci 2005; 8:287-295.
19. Ishizuka T, Nomura S, Hosoda H, et al. A role of the histaminergic system for the control of feeding by orexigenic peptides. Physiol Behav 2006; 89:295-300.
20. Sakata I, Yamazaki M, Inoue K, et al. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett 2003; 342:183-186.
21. Burdyga G, Varro A, Dimaline R, et al. Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance. Am J Physiol Gastrointest Liver Physiol 2006; 290:G1289-G1297.
22. Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123:1120-1128.
23. le Roux CW, Neary NM, Halsey TJ, et al. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 2005; 90:4521-4524.
24. Arnold M, Mura A, Langhans W, Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci 2006; 26:11052-11060.
25. Soriano-Guillen L, Barrios V, Campos-Barros A, Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 2004; 144:36-42.
26. Williams DL, Grill HJ, Cummings DE, Kaplan JM. Overfeeding-induced weight gain suppresses plasma ghrelin levels in rats. J Endocrinol Invest 2006; 29:863-868.
27. Palik E, Baranyi E, Melczer Z, et al. Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract 2007; 76:351-357.
28. Hosojima H, Togo T, Odawara T, et al. Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia. J Psychopharmacol 2006; 20:75-79.
29. Otukonyong EE, Dube MG, Torto R, et al. High-fat diet-induced ultradian leptin and insulin hypersecretion are absent in obesity-resistant rats. Obes Res 2005; 13:991-999.
30. Purnell JQ, Cummings D, Weigle DS. Changes in 24-h area-under-the-curve ghrelin values following diet-induced weight loss are associated with loss of fat-free mass, but not with changes in fat mass, insulin levels or insulin sensitivity. Int J Obes (Lond) 2007; 31:385-389. After diet-induced weight loss, changes in ghrelin levels might be a signal reflecting changes in fat-free mass to the hypothalamus.
31. Kraemer RR, Castracane VD. Exercise and humoral mediators of peripheral energy balance: ghrelin and adiponectin. Exp Biol Med (Maywood) 2007; 232:184-194.
32. Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001; 104:2034-2038.
33. Shimizu Y, Nagaya N, Isobe T, et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 2003; 9:774-778.
34. Wolf I, Sadetzki S, Kanety H, et al. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 2006; 106:966-973.
35. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346:1623-1630.
36. Fruhbeck G, Diez CA, Gil MJ. Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med 2004; 350:308-309.
37. Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) 2006; 14:1553-1561.
38. Chan JL, Mun EC, Stoyneva V, et al. Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring) 2006; 14:194-198.
39. Mancini MC, Costa AP, de Melo ME, et al. Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles. Obesity (Silver Spring) 2006; 14:383-387.
40. Couce ME, Cottam D, Esplen J, et al. Is ghrelin the culprit forweight loss after gastric bypass surgery? A negative answer. Obes Surg 2006; 16:870-878.
41. Stenstrom B, Zhao CM, Tommeras K, et al. Is gastrin partially responsible for body weight reduction after gastric bypass? Eur Surg Res 2006; 38:94-101.
42. Mingrone G, Granato L, Valera-Mora E, et al. Ultradian ghrelin pulsatility is disrupted in morbidly obese subjects after weight loss induced by malabsorptive bariatric surgery. Am J Clin Nutr 2006; 83:1017-1024.
43. Stratis C, Alexandrides T, Vagenas K, Kalfarentzos F. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study. Obes Surg 2006; 16:752-758.
44. Haider DG, Schindler K, Prager G, et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007; 92:1168-1171.
45. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407:908-913.
46. Tsubone T, Masaki T, Katsuragi I, et al. Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regul Pept 2005; 130:97-103.
47. Wortley KE, Anderson KD, Garcia K, et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 2004; 101:8227-8232.
48. Thompson NM, Gill DA, Davies R, et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 2004; 145:234-242.
49. Kim MS, Yoon CY, Jang PG, et al. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol 2004; 18:2291-2301.
50. Muccioli G, Pons N, Ghe C, et al. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a nontype 1a growth hormone secretagogue receptor. Eur J Pharmacol 2004; 498:27-35.
51. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 2006; 116:1983-1993. This is a very complete description of ghrelin actions on white and brown adipose tissue, demonstrating the physiological relevance of central ghrelin in the control of adipocyte metabolism.
52. Deboer MD, Zhu XX, Levasseur P, et al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 2007; 148:3004-3012. In cancer cachexia, weight gain and lean-body-mass retention are improved by ghrelin and synthetic ghrelin agonists.
53. Bertoli S, Magni P, Krogh V, et al. Is ghrelin a signal of decreased fat-free mass in elderly subjects? Eur J Endocrinol 2006; 155:321-330.
54. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 2003; 23:7973-7981.
55. Wortley KE, Del Rincon JP, Murray JD, et al. Absence of ghrelin protects against early-onset obesity. J Clin Invest 2005; 115:3573-3578.
56. Cummings DE, Clement K, Purnell JQ, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 2002; 8:643-644.
57. DelParigi A, Tschop M, Heiman ML, et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. J Clin Endocrinol Metab 2002; 87:5461-5464.
58. Gimenez-Palop O, Gimenez-Perez G, Mauricio D, et al. A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response. Clin Endocrinol (Oxf) 2007; 66:198-204. In PWS, the postprandial decrease in ghrelin concentrations is lower in PWS compared to lean and obese subjects and might be related to the low fasting PYY concentrations.
59. Paik KH, Choe YH, Park WH, et al. Suppression of acylated ghrelin during oral glucose tolerance test is correlated with whole-body insulin sensitivity in children with Prader-Willi syndrome. J Clin Endocrinol Metab 2006; 91:1876-1881.
60. Erdie-Lalena CR, Holm VA, Kelly PC, et al. Ghrelin levels in young children with Prader-Willi syndrome. J Pediatr 2006; 149:199-204.
61. Sun Y, Asnicar M, Saha PK, et al. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006; 3:379-386.
62. Shintani M, Ogawa Y, Ebihara K, et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50:227-232.
63. Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001; 411:480-484.
64. Nagaya N, Kojima M, Kangawa K. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia. Intern Med 2006; 45:127-134.
65. Miljic D, Pekic S, Djurovic M, et al. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab 2006; 91:1491-1495. This study suggests that ghrelin might not be useful for anorexia-nervosa-induced cachexia because these patients seem less sensitive to ghrelin in terms of appetite than healthy controls.
66. Asakawa A, Inui A, Kaga T, et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003; 52:947-952.
67. Beck B, Richy S, Stricker-Krongrad A. Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats. Life Sci 2004; 76:473-478.
68. Shearman LP, Wang SP, Helmling S, et al. Ghrelin neutralization by an RNA-Spiegelmer ameliorates obesity in diet-induced obese mice. Endocrinology 2005; 147:1517-1526.
69. Kobelt P, Helmling S, Stengel A, et al. Antighrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats. Gut 2006; 55:788-792. This is an excellent paper demonstrating the efficiency of antighrelin oligonucleotides on appetite and food intake.
70. Shearman LP, Wang SP, Helmling S, et al. Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice. Endocrinology 2006; 147:1517-1526.
71. Zorrilla EP, Iwasaki S, Moss JA, et al. Vaccination against weight gain. Proc Natl Acad Sci USA 2006; 103:13226-13231. This paper describes a new approach to inhibit the endogenous ghrelin. Vaccination against ghrelin decreases ghrelin levels and might slowweight gain by reducing feed efficiency.
72. Holst B, Cygankiewicz A, Jensen TH, et al. High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Mol Endocrinol 2003; 17:2201-2210.
73. Holst B, Schwartz TW. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacol Sci 2004; 25:113-117.